Filing
Spy
Filing
Spy
Home
About
KITE
Kite Pharma Inc
Clinical-stage biopharmaceutical company developing cancer immunotherapies
CUSIP: 49803L109
Healthcare
US
1 holder
Ownership
Activity
Fundamentals
2014 Q3
10 of 10 quarters
Total Value
$5.70M
Total Shares
200.0K
Net Share Change
+200.0K
Activity
1 buying
Investor
Value
Shares
Weight
Change
Viking Global Investors
$5.70M
200.0K
0.0%
NEW
Viking Global Investors
$5.70M
200.0K shares
NEW
KITE — Kite Pharma Inc - FilingSpy